GE9:F:F-Genmab A/S (EUR)

COMMON STOCK | |

Last Closing

USD 273.4

Change

+8.00 (+3.01)%

Market Cap

USD 16.86B

Volume

45.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
NNND:F Tencent Holdings Ltd

+0.38 (+0.83%)

USD 423.18B
MATA:F Panasonic Corporation

N/A

USD 20.38B
1CK:F CK Asset Holdings Limited

+0.02 (+0.50%)

USD 14.78B
0PY:F Paycom Soft

+1.45 (+0.88%)

USD 9.65B
KMBA:F SK TELECOM CO.LTD.ADR 5/9

N/A

USD 7.45B
UIPN:F Unipol Gruppo Finanziario Spa

+0.02 (+0.22%)

USD 6.28B
2U4:F HICL Infrastructure PLC

N/A

USD 2.70B
CLN:F The City of London Investment ..

+0.01 (+0.20%)

USD 1.93B
3A2:F AVZ Minerals Limited

N/A

USD 1.87B
R7I:F RENEWABLES INFRASTRUCTURE

N/A

USD 1.82B

ETFs Containing GE9:F

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.87% N/A N/A 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.87% N/A N/A 34% F
Trailing 12 Months  
Capital Gain -24.85% N/A N/A 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -24.85% N/A N/A 24% F
Trailing 5 Years  
Capital Gain 84.23% N/A N/A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.23% N/A N/A 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 17.80% N/A N/A 86% B+
Dividend Return 17.80% N/A N/A 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.44% N/A N/A 34% F
Risk Adjusted Return 54.87% N/A N/A 85% B
Market Capitalization 16.86B N/A N/A 90% A-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike